Managing patients with restless legs

Drug and Therapeutics Bulletin

Volumn 41, Issue 11, 2003, Pages 81-83

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

BROMOCRIPTINE; CABERGOLINE; CAFFEINE; CALCIUM ANTAGONIST; CARBAMAZEPINE; CARBIDOPA; CENTRAL STIMULANT AGENT; CLONAZEPAM; CLONIDINE; DECARBOXYLASE INHIBITOR; DIURETIC AGENT; GABAPENTIN; LEVODOPA; LISURIDE; OXYCODONE; PERGOLIDE; PHENYTOIN; PLACEBO; PRAMIPEXOLE; ROPINIROLE; TRICYCLIC ANTIDEPRESSANT AGENT;

ABDOMINAL PAIN; ARM; BURNING SENSATION; CLINICAL FEATURE; CLINICAL TRIAL; COUGHING; DIAGNOSTIC ERROR; DIAGNOSTIC PROCEDURE; DISEASE EXACERBATION; DISTRESS SYNDROME; DROWSINESS; DRUG DEPENDENCE; DRUG DOSE REGIMEN; DRUG EFFICACY; DYSPNEA; FREQUENCY ANALYSIS; GENETIC SUSCEPTIBILITY; HEART FAILURE; HEART MUSCLE FIBROSIS; HUMAN; INSOMNIA; LEG CRAMP; LEG PAIN; LUNG FIBROSIS; MUSCLE WEAKNESS; NEUROSIS; PARESTHESIA; PATIENT CARE; QUALITY OF LIFE; RELAXATION TRAINING; RESTLESS LEGS SYNDROME; RETROPERITONEAL FIBROSIS; REVIEW; SENSORIMOTOR FUNCTION; SENSORY DYSFUNCTION; SLEEP; SOMNOLENCE; SYMPTOMATOLOGY; THORAX PAIN; TRUNK; WAKEFULNESS;

EID: 0345308432     PISSN: 00126543     EISSN: None     Source Type: Journal    
DOI: 10.1136/dtb.2003.411181     Document Type: Review

References (29)

1. Lavigne GJ, Montplaisir JY. Restless syndrome and sleep bruxism: prevalence and association among Canadians. Sleep 1994; 17: 739-43.
2. Chaudhari KR. The restless leg syndrome. Time to recognized a very common movement disorder. Practical Neurol 2003; 3: 204-13.
3. Rye DB. Modulation of normal and pathologic motoneuron activity during sleep: insights from the neurology clinic, Parkinson's disease, and comments on parkinsonian-related sleepiness. Sleep Med 2002; 3: S43-9.
4. Connor JR et al. Neuropathological examination suggests impaired brain iron acquisition in restless legs syndrome. Neurology 2003; 61: 304-9.
5. Earley CJ. Restless legs syndrome. N Engl J Med 2003; 348: 2103-9.
6. Goodman JD et al. Restless leg syndrome in pregnancy. BMJ 1988; 297: 1101-2.
7. Walters AS for the International Restless Legs Syndrome Study Group. Toward a better definition of the restless legs syndrome. Mov Disord 1995; 10: 634-42.
8. Ondo W, Jankovic J. Restless legs syndrome: clinicoetiologic correlates. Neurology 1996; 47: 1435-41.
9. Desautels A et al. Identification of a major susceptibility locus for restless legs syndrome on chromosome 12q. Am J Hum Genet 2001; 69: 1266-70.
10. Bonati MT et al. Autosomal dominant restless legs syndrome maps on chromosome 14q. Brain 2003; 126: 1485-92.
11. Hening W et al. The treatment of restless legs syndrome and periodic limb movement disorder. Sleep 1999; 22: 970-99.
12. Allen RP, Earley CJ. Augmentation of the restless syndrome with carbidopa/levodopa. Sleep 1996; 19: 205-13.
13. Earley CJ et al. Randomized, double-blind placebo-controlled trial of pergolide in restless legs syndrome. Neurology 1998; 51: 1599-602.
14. Wetter TC et al. A randomized controlled study of pergolide in patients with restless legs syndrome. Neurology 1999; 52: 944-50.
15. Walters AS et al. A double-blind randomized crossover trial of bromocriptine and placebo in restless legs syndrome. Ann Neurol 1998; 24: 455-8.
16. Montplaisir J et al. Restless legs syndrome improved by pramipexole. A double-blind randomized trial. Neurology 1999; 52: 938-43.
17. Montplaisir J et al. Pramipexole in the treatment of restless legs syndrome: a follow-up study. Eur J Neurol 2000; 7 (suppl 1): 27-31.
18. Saletu M et al. Sleep laboratory studies in restless legs syndrome patients as compared with normals and acute effects of ropinirole. Neuropsychiatry 2000; 41: 190-9.
19. Saletu M et al. Acute placebo-controlled sleep laboratory studies and clinical follow-up with pramipexole in restless legs syndrome. Eur Arch Psychiatry Clin Neurosci 2002; 252: 185-94.
20. Stiasny K et al. Treatment if idiopathic restless legs syndrome (RLS) with the D2-agonst cabergoline - an open clinical trial. Sleep 2000; 23: 349-54.
21. Staedt J et al. Pergolide: treatment of choice in restless legs syndrome (RLS) and nocturnal myoclonus syndrome (NMS). A double-blind randomized crossover trial of pergolide versus L-dopa. J Neural Transm 1997; 104: 461-8.
22. Ferini-Strambi L. Restless legs syndrome augmentation and pramipexole treatment. Sleep Med 2002; 3: S23-5.
23. Joint Formulary Committee. British National Formulary. Edition 46. London: Royal Pharmaceutical Society of Great Britain Medical Association, September 2003.
24. Garcia-Borreguero D et al. Treatment of restless legs syndrome with gabapentin. A double-blind, cross-over study. Neurology 2002; 29: 1573-9.
25. Happe S et al. Gabapentin versus ropinirole in the treatment of idiopathic restless legs syndrome. Neuropsychobiology 2003; 48: 82-6.
26. Telstad W et al. Treatment of the restless legs syndrome with carbamazepine: a double blind study. BMJ 1984; 288: 444-6.
27. Saletu M et al. Restless legs syndrome (RLS) and periodic limb movement disorder (PLMD). Acute placebo-controlled sleep laboratory studies with clonazepam. Eur Neuropsychopharmacol 2001; 11: 153-61.
28. Walters AS et al. Successful treatment of the idiopathic restless legs syndrome in a randomized double-blind trial of oxycodone versus placebo. Sleep 1993; 16: 327-32.
29. Wagner ML et al. Randomized, double-blind, placebo-controlled study of clonidine in restless legs syndrome. Sleep 1996; 19: 52-8.